Pharmaceutical

Searchlight licenses Mithra’s menopause drug Donesta for Canadian market

Mithra Pharmaceuticals is in line to receive €17.05m ($18.8m) in licencing fees, and milestone-based payments.

Jul 31, 2023 - 20:00
Searchlight licenses Mithra’s menopause drug Donesta for Canadian market
Mithra Pharmaceuticals is in line to receive €17.05m ($18.8m) in licencing fees, and milestone-based payments.
Read the original article

Tags:

Previous Article

Non-profit receives FDA approval to supply cheaper OTC naloxone

Next Article

Santhera fully divests rare eye disease drug Raxone to Chiesi

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug

Merck KGaA abandons Phase III trial for $1.08bn head & ...

Jun 26, 2024

FDA yet to find link between suicidal risk and GLP-1RA use

FDA yet to find link between suicidal risk and GLP-1RA use

Jan 13, 2024

STAT+: Patients loved Carbon Health’s diabetes program. That couldn’t save it

STAT+: Patients loved Carbon Health’s diabetes program....

Nov 13, 2023